Past events
Our events programme, whether face to face, virtual or hybrid, plays a significant part in facilitating connections and advancing innovations.
10 Oct 2023 - 13 Oct 2023 BioJapan 2023
MedCity, the life sciences cluster organisation for London, is delighted to be leading the UK delegation to BioJapan for the seventh year.
19 Apr 2023 Diagnostics Growth Hub series: Biomarker Matchmaking 2023
The Biomedical Research Exchange for Academia, Clinicians and Health Tech (BREACH) and the Medicine Discovery Catapult are bring together the second Biomarker Matchmaking event in the series.
14 Mar 2023 UK Life Sciences Summit 2023
The event is brought to you by MedCity and the Northern Health Science Alliance (NHSA) to demonstrate the growth and excellence across the UK Life Sciences sector and what more could be achieved by bringing together investors and innovators in this area.
8 Feb 2023 Advances in Clinical Trials- Faster and Better. Equality, Diversity & Inclusion in Clinical Trials Roundtable
MedCity and NIHR are organising a Roundtable focusing on EDI in Clinical Trials; as part of the Faster and Better series
19 Jan 2023 Collaborate to Innovate Networking Event
Collaborate to Innovate Networking: Featuring Advanced Therapies, Stroke Therapies and London Diagnostics Cohorts
22 Nov 2022 UKAT: Introduction to the Innovation Hubs for Gene Therapies, in partnership with MRC and LifeArc
This event will introduce the Advanced Therapies Network to the Innovation Hubs for Gene Therapies.
10 Oct 2022 UKAT: Commercialisation of academic research in cell and gene therapies- successes and investment opportunities from the UKAT
Commercialisation of academic research in cell and gene therapies panel discussion satellite event the the ESGCT / BSGCT Annual Congress
16 Jun 2022 The Innovation Gateway Showcase
Showcasing The Innovation Gateway In Partnership with Medcity
17 May 2022 Advances in Clinical Trials- ‘Faster and Better’- Decentralised Trials
MedCity and NIHR are organising their 2nd event in the ‘faster and better’ series to promote collaboration between companies and NHS Foundation Trusts to demonstrate ‘the art of the possible’ and to promote shared learning between those sites that are already engaged in novel ways to conduct trials.